Federal Court upholds validity of patent relating to paliperidone palmitate | Smart & Biggar

On August 23, 2022, the Federal Court issued its public judgment and reasons in two actions under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations (the...

Related Keywords

Canada ,Canadian ,Teva Paliperidone ,Teva ,Janssen Incv Pharmascience Inc ,Janssen Incv Apotex Inc ,Janssen Incv Teva Canada Ltd ,Federal Court ,Patented Medicines ,Canadian Patent ,Janssen Inc ,Pharmascience Inc ,Teva Canada Ltd ,Apotex Inc ,